| Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210) |
|---|
| 02/03/2000 | CA2335655A1 Keratinocyte derived interferon |
| 02/03/2000 | CA2335653A1 Molecules associated with cell proliferation |
| 02/03/2000 | CA2335646A1 Genes of the dead box protein family, their expression products and use |
| 02/03/2000 | CA2335392A1 Methods and compositions for the determination of protein function and identification of modulators thereof |
| 02/03/2000 | CA2335390A1 Substantially complete ribozyme libraries |
| 02/03/2000 | CA2335378A1 Methods and compositions for the diagnosis and treatment of body weight disorders, including obesity |
| 02/03/2000 | CA2335345A1 Human calcium regulatory proteins |
| 02/03/2000 | CA2335343A1 Novel methods for the identification of ligand and target biomolecules |
| 02/03/2000 | CA2335326A1 Nucleotide sequences and amino acid sequences of secreted proteins involved in angiogenesis |
| 02/03/2000 | CA2335278A1 Method for screening of modulators of calcineurin activity |
| 02/03/2000 | CA2335276A1 Nucleic acid detection method by triple helix formation |
| 02/03/2000 | CA2334942A1 Novel protein and its dna |
| 02/03/2000 | CA2334047A1 Hybrid human/rodent igg antibody to cd3, and methods of its construction |
| 02/03/2000 | CA2334042A1 Orphan cytokine receptor |
| 02/03/2000 | CA2333302A1 Antibodies for the dectection of beer spoilage lactic acid bacteria, method of detection using the antibodies, and kit employing the antibodies |
| 02/03/2000 | CA2333146A1 Commercial production of proteases in plants |
| 02/03/2000 | CA2332487A1 Quantitative analysis of gene expression using pcr |
| 02/03/2000 | CA2328449A1 Antibody-mediated down-regulation of plant proteins |
| 02/03/2000 | CA2303977A1 Expression of enzymes involved in cellulose modification |
| 02/03/2000 | CA2303919A1 Plant phosphatidic acid phosphatases |
| 02/02/2000 | EP0976838A1 Enzymes mixture |
| 02/02/2000 | EP0976837A2 Oligonucleotides for detecting enteric hemorrhagic e. coli and detection method using the same |
| 02/02/2000 | EP0976836A1 Digital hybridization screening |
| 02/02/2000 | EP0976834A2 Liquid reagent for calcium assay |
| 02/02/2000 | EP0976832A2 Promoter functional in a plant cell |
| 02/02/2000 | EP0976831A1 Method of genetic modification of a wild type viral sequence |
| 02/02/2000 | EP0976829A2 Protein-deamidating enzyme, gene encoding the same, production process therefor, and use thereof |
| 02/02/2000 | EP0976828A1 Fungal D-aminoacylases and method for producing D-amino acids |
| 02/02/2000 | EP0976827A1 Xylitol dehydrogenase of acetic acid bacteria and gene thereof |
| 02/02/2000 | EP0976826A1 Gene encoding recombinant trehalose phosphorylase, vector containing the gene, transformant transformed by the gene, and method for producing recombinant trehalose phosphorylase with the use of the transformant |
| 02/02/2000 | EP0976825A1 Transcriptional regulator |
| 02/02/2000 | EP0976824A1 Gene and protein involved in liver regeneration |
| 02/02/2000 | EP0976823A1 Recombinant expression system and high throughput BioAssay for the therapeutic use of calcineurine-A- alpha, calcineurine-A-beta, calcineurine-A-gamma, calcineurine-B und Cu/Zn-superoxide dismutase respectively for the identification of pharmaceuticals |
| 02/02/2000 | EP0976822A2 Recombinant pectinmethylesterase and use thereof |
| 02/02/2000 | EP0976764A1 Novel membrane-secreted protein |
| 02/02/2000 | EP0975964A1 In situ identification of target structures e.g. in vivo selection method for a phage library |
| 02/02/2000 | EP0975810A1 Method of pcr testing of pooled blood samples |
| 02/02/2000 | EP0975809A1 Novel screening methods to identify agents that selectively inhibit hepatitis c virus replication |
| 02/02/2000 | EP0975808A2 Topologically fixed matrix bonded nucleic acid molecule |
| 02/02/2000 | EP0975807A1 Two-step hybridization and capture of a polynucleotide |
| 02/02/2000 | EP0975806A1 Compositions and methods for reverse transcriptase-polymerase chain reaction (rt-pcr) |
| 02/02/2000 | EP0975805A1 Hybridisation assay in which excess probe is destroyed |
| 02/02/2000 | EP0975804A2 Amplification based mutation detection |
| 02/02/2000 | EP0975802A1 Method of nucleic acid sequencing |
| 02/02/2000 | EP0975801A1 METHODS FOR SCREENING FOR ANTIMICROBIALS UTILIZING (aarC) AND COMPOSITIONS THEREOF |
| 02/02/2000 | EP0975800A1 Assaying nucleotides in solution using pna probes |
| 02/02/2000 | EP0975799A1 Means for identifying nucleotide sequences involved in apomixis |
| 02/02/2000 | EP0975798A1 Method to diagnose and treat pathological conditions resulting from deficient ion transport such as pseudohypoaldosteronism type-1 |
| 02/02/2000 | EP0975796A1 Screen employing fluorescence anisotropy to identify compounds with affinity for nucleic acids |
| 02/02/2000 | EP0975793A1 Interactions of skn7 gene and its use in assay methods |
| 02/02/2000 | EP0975787A1 Entomopoxvirus-based gene delivery vector for vertebrates |
| 02/02/2000 | EP0975786A2 Novel transgene expression system for increased persistence |
| 02/02/2000 | EP0975785A1 Adenoviral vectors comprising a modified e4 region but retaining e4orf3 |
| 02/02/2000 | EP0975783A2 Retroviral vectors, method for the production and the use thereof for gene transfer in cd4-positive cells |
| 02/02/2000 | EP0975782A1 Novel adenoviral vectors capable of facilitating increased persistence of transgene expression |
| 02/02/2000 | EP0975780A2 Il-2 gene expression and delivery systems and uses |
| 02/02/2000 | EP0975779A1 Oxidative stress resistance gene |
| 02/02/2000 | EP0975778A1 Glyphosate resistant maize lines |
| 02/02/2000 | EP0975777A1 Methods of commercial production and extraction of protein from seed |
| 02/02/2000 | EP0975776A1 Gene involved in basidiomycete fungi fruit body development and uses |
| 02/02/2000 | EP0975775A2 Regulatory system for inducible expression of genes with lambdoid promoters |
| 02/02/2000 | EP0975774A2 Bacterial plasmids |
| 02/02/2000 | EP0975773A1 Dna sequences, molecules, vectors and vaccines for feline calicivirus disease and methods for producing and using same |
| 02/02/2000 | EP0975772A1 Reagents and methods useful for detecting diseases of the gastrointestinal tract |
| 02/02/2000 | EP0975771A1 Type ii tgf-beta receptor/immunoglobulin constant region fusion proteins |
| 02/02/2000 | EP0975770A1 Selection marker |
| 02/02/2000 | EP0975769A1 Novel prostate-associated kallikrein |
| 02/02/2000 | EP0975768A2 Phenolic acid esterase and use thereof |
| 02/02/2000 | EP0975767A1 Nucleic acids encoding a plant enzyme involved in very long chain fatty acid synthesis |
| 02/02/2000 | EP0975766A1 Methods and compositions for synthesis of long chain polyunsaturated fatty acids |
| 02/02/2000 | EP0975765A1 Plant fatty acid epoxygenase genes and uses therefor |
| 02/02/2000 | EP0975764A1 A gene delivery vehicle expressing the apoptosis-inducing proteins vp2 and/or apoptin |
| 02/02/2000 | EP0975763A1 Bacillus thuringiensis isolates with broad spectrum activity |
| 02/02/2000 | EP0975762A1 Type-1 ribosome-inactivating protein |
| 02/02/2000 | EP0975761A1 Recombinant human beta interferon with enhanced solubility |
| 02/02/2000 | EP0975760A1 Motilin homologs |
| 02/02/2000 | EP0975759A1 Human tumor-associated kazal inhibitor |
| 02/02/2000 | EP0975758A1 POLYPEPTIDE HAVING A GTPase REGULATOR ACTIVITY, NUCLEIC ACIDS CODING THEREFOR AND THEIR USE IN DIAGNOSTICS AND THERAPY |
| 02/02/2000 | EP0975757A2 Dictyocaulus viviparus antigen for the diagnosis of lungworm disease and for vaccination |
| 02/02/2000 | EP0975756A1 Fibroblasts with a foreign gene-containing composition for treating wounds |
| 02/02/2000 | EP0975755A1 Crsp protein (cysteine-rich secreted proteins), nucleic acid molecules encoding them and uses therefor |
| 02/02/2000 | EP0975754A1 Osteoprotegerin binding proteins and receptors |
| 02/02/2000 | EP0975753A2 $g(b)-AMYLOID PEPTIDE-BINDING PROTEINS AND POLYNUCLEOTIDES ENCODING THE SAME |
| 02/02/2000 | EP0975752A1 Human cerberus protein |
| 02/02/2000 | EP0975751A1 A tm4sf human tumor-associated antigen |
| 02/02/2000 | EP0975750A2 Modified retinoblastoma tumor suppressor proteins |
| 02/02/2000 | EP0975749A2 Cc chemokine receptor 5, antibodies thereto, transgenic animals |
| 02/02/2000 | EP0975748A1 Methods dor identifying nucleic acid molecules encoding (poly)peptides that interact with target molecules |
| 02/02/2000 | EP0975747A1 Polypeptide capable of reacting with antibodies of patients suffering from multiple sclerosis and uses |
| 02/02/2000 | EP0975746A1 Transgenic mouse expressing human cd4 and fusin (cxcr4) |
| 02/02/2000 | EP0975745A1 Extracellular expression of cellulose binding domains (cbd) using bacillus |
| 02/02/2000 | EP0975742A1 Aminopeptidase derived from bacillus licheniformis and process for preparation of natural type proteins |
| 02/02/2000 | EP0975741A2 Alpha/beta hydrolase-fold enzymes |
| 02/02/2000 | EP0975737A1 $i(CHLORELLA) VIRUS PROMOTERS |
| 02/02/2000 | EP0975674A1 Immunotoxins, comprising an onc protein, directed against malignant cells |
| 02/02/2000 | EP0975672A1 Antibodies for inhibiting blood coagulation and methods of use thereof |
| 02/02/2000 | EP0975668A1 MODIFIED TNF$g(a) MOLECULES, DNA ENCODING SUCH MODIFIED TNF$g(a) MOLECULES AND VACCINES COMPRISING SUCH MODIFIED TNF$g(a) MOLECULES AND DNA |
| 02/02/2000 | EP0975666A2 Compositions and methods for the treatment and diagnosis of breast cancer |
| 02/02/2000 | EP0975664A1 Aatt promoter element and transcription factor |
| 02/02/2000 | EP0975663A1 Helicobacter pylori antigens |